Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

BACKGROUND: ROS1 gene rearrangement has been reported in several types of cancers, including non-small cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors are effective in the treatment of ROS1-rearranged NSCLC. Therefore, the identification of ROS1 rearrangement can be used as...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Huanhuan, Ren, Dunqiang, Ding, Xiaoqian, Yin, Xiaojiao, Cui, Shichao, Guo, Caihong, Wang, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797378/
https://www.ncbi.nlm.nih.gov/pubmed/35117804
http://dx.doi.org/10.21037/tcr-20-1813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797378/
https://www.ncbi.nlm.nih.gov/pubmed/35117804
http://dx.doi.org/10.21037/tcr-20-1813

Ejemplares similares